3 Growth Stocks With Insider Ownership Expecting Up To 71% Earnings Growth

In This Article:

As global markets experience a rebound fueled by easing core U.S. inflation and strong bank earnings, the focus has shifted to how growth stocks are navigating these conditions. In this environment, companies with substantial insider ownership often attract attention due to their potential alignment of interests between management and shareholders, suggesting confidence in the company's future prospects.

Top 10 Growth Companies With High Insider Ownership

Name

Insider Ownership

Earnings Growth

Kirloskar Pneumatic (BSE:505283)

30.3%

26.3%

Archean Chemical Industries (NSEI:ACI)

22.9%

41.2%

Clinuvel Pharmaceuticals (ASX:CUV)

10.4%

26.2%

People & Technology (KOSDAQ:A137400)

16.4%

37.3%

SKS Technologies Group (ASX:SKS)

29.7%

24.8%

Medley (TSE:4480)

34.1%

27.2%

Plenti Group (ASX:PLT)

12.7%

120.1%

Fine M-TecLTD (KOSDAQ:A441270)

17.2%

135%

HANA Micron (KOSDAQ:A067310)

18.3%

108.3%

Findi (ASX:FND)

35.8%

110.7%

Click here to see the full list of 1464 stocks from our Fast Growing Companies With High Insider Ownership screener.

Underneath we present a selection of stocks filtered out by our screen.

Pharma Mar

Simply Wall St Growth Rating: ★★★★★★

Overview: Pharma Mar, S.A. is a biopharmaceutical company focused on the research, development, production, and commercialization of bio-active principles for oncology across various regions including Europe and the United States, with a market cap of €1.40 billion.

Operations: The company's revenue is primarily derived from its oncology segment, which generated €154.75 million.

Insider Ownership: 11.9%

Earnings Growth Forecast: 55.1% p.a.

Pharma Mar demonstrates potential as a growth company with high insider ownership, highlighted by its forecasted earnings growth of 55.1% annually, outpacing the Spanish market's 8.2%. Despite recent volatility in share price and declining profit margins from 8.3% to 0.4%, it trades at a significant discount to estimated fair value and shows strong revenue growth prospects at 25.5% per year, surpassing the market's expected rate of 4.9%.

BME:PHM Ownership Breakdown as at Jan 2025
BME:PHM Ownership Breakdown as at Jan 2025

Yijiahe Technology

Simply Wall St Growth Rating: ★★★★★☆

Overview: Yijiahe Technology Co., Ltd. focuses on the research and development, design, and sale of intelligent robots in China, with a market capitalization of CN¥5.31 billion.

Operations: The company's revenue is derived from its activities in the research, development, design, and sale of intelligent robots within China.